Clinical Trial Update: Memantine Hydrochloride in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating memantine hydrochloride in metastatic castration-resistant prostate cancer and other prostate cancers, currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Neuroendocrine Prostate Cancer
• Prostate Cancer

Drugs mentioned

• MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

Sponsor: Bin Xu | Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING